The relationship between migraine and vision extends well beyond the visual aura that is perhaps the best-known visual feature of the condition. Visual symptoms in migraine encompass a broad spectrum — from the transient scintillating scotomas of migraine aura to persistent visual phenomena that occur between attacks, from the acute photophobia of the attack itself to the chronic light sensitivity that characterizes the migraine nervous system in the interictal period, and from the eye strain that contributes to attack precipitation to the rare but clinically significant visual complications associated with migraine with aura.
Visual aura is the most recognized visual manifestation of migraine, affecting approximately thirty percent of people with the condition. The most common form is a scintillating scotoma, a crescent-shaped region of flickering or shimmering light that begins near the center of the visual field and expands toward the periphery over fifteen to thirty minutes, leaving a blind spot in its wake.
Visual aura reflects cortical spreading depression moving across the visual cortex. As the wave of electrical change traverses the visual cortex, it first activates and then suppresses the neurons responsible for processing different regions of the visual field. The expanding arc of the scintillating scotoma corresponds to the leading edge of cortical spreading depression activation, while the blind spot corresponds to the zone of neuronal suppression that follows.
Some people with migraine experience visual symptoms that persist between attacks or do not resolve after aura should have ended. Visual snow syndrome is characterized by a continuous static or snow-like visual disturbance covering the entire visual field, along with other visual phenomena including afterimages, palinopsia, and visual trailing. Visual snow syndrome frequently co-occurs with migraine and may reflect a form of cortical hyperexcitability that produces ongoing abnormal visual processing.
Persistent aura without infarction is a rare condition in which aura symptoms persist for more than one week without evidence of stroke on neuroimaging. This condition requires careful evaluation to exclude migraine infarction, a rare complication in which migraine aura is associated with actual ischemic injury.
Photophobia, the acute pain and sensitivity to light during migraine attacks, is present in the majority of people with migraine and is one of the diagnostic criteria for the condition. The pathway involves melanopsin-containing retinal ganglion cells that project to thalamic and brainstem regions involved in pain processing, providing a direct route through which light activates the migraine pain system.
Between attacks, many people with migraine experience persistent light sensitivity that is subtler than ictal photophobia but functionally significant. This interictal light sensitivity reflects the baseline hyperexcitability of the migraine nervous system and may manifest as discomfort in bright environments, difficulty with fluorescent lighting, and visual fatigue with screen use.
Certain eye conditions are associated with migraine and warrant ophthalmological evaluation. Dry eye disease is more prevalent in people with migraine than in headache-free populations, possibly reflecting shared autonomic nervous system dysregulation affecting lacrimal gland function. Digital eye strain, a significant source of ocular discomfort in screen-intensive work environments, is a modifiable contributor to migraine via the trigeminal-ocular pathway.
People with migraine who experience new or changing visual symptoms should seek evaluation to distinguish migraine-related visual phenomena from conditions requiring separate treatment. A sudden change in aura pattern, new onset of persistent visual symptoms, monocular visual loss, or visual symptoms that do not follow the typical gradual onset and progression of migraine aura all warrant prompt evaluation. An ophthalmologist or neuro-ophthalmologist with experience in migraine-related visual conditions is the appropriate specialist for complex visual presentations in migraine.
Noseda R, Bernstein CA, Nir RR, et al. Migraine photophobia originating in cone-driven retinal pathways. Brain. 2016.
Schankin CJ, Maniyar FH, Digre KB, Goadsby PJ. Visual snow — a disorder distinct from persistent migraine aura. Brain. 2014.
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018.
American Migraine Foundation. Ocular Migraine. americanmigrainefoundation.org
Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiological Reviews. 2017.
Vestibular migraine diagnostic criteria, how it differs from Meniere disease, interictal vestibular dysfunction, motion sickness, diagnosis, and treatment including vestibular rehabilitation.
Prevalence of tinnitus in migraine, auditory cortex hyperexcitability, the trigeminal-auditory connection, vestibular migraine and auditory symptoms, and coordinated management.
Co-occurrence rates, the enteric nervous system and serotonin, mast cells as a connecting mechanism, shared nausea pathways, and treatments that address both conditions.
What central sensitization is, how it manifests in both conditions, reduced descending pain inhibition, clinical implications of co-occurrence, and treatment overlap.
Tracking your migraines changes everything. MigraClarity helps you log attacks, identify triggers, monitor medications, and track sleep and hydration — then generates a provider-ready report you can bring to your next appointment. Create your free account and start building a clearer picture of your migraine pattern today.
Create Your Free AccountThe information in this article is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional or licensed physician before making any decisions about your health, medications, or treatment. MigraClarity is not a medical provider and nothing on this site should be used as a substitute for professional medical care.